跳至主要内容
临床试验/DRKS00024838
DRKS00024838尚未招募不适用

Myeloid Cells` Immunosuppressive activity in Sepsis - MyCIS

Klinik für Anästhesiologie - Universitätsklinikum Heidelberg0 个研究点目标入组 100 人开始时间: 2021年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with Sepsis:
  • Consent by the legal representative
  • At least 2 SIRS criteria met:
  • - temperature <36ºC or> 38ºC
  • - tachycardia (> 90 /min)
  • - leukocytosis (> 12,000 /µl) OR leukopenia (<4,000 /µl) OR left shift (>10% immature blasts)
  • - Tachypnea (> 20 /min) OR paCO2 <32 mmHg OR oxygenation index (FiO2/paO2) <200 OR mechanical Ventilation
  • Clinical or microbiological evidence of infection
  • Sepsis-associated organ dysfunction indicated by a change in the Sequential Organ Failure Assessment (SOFA) score by 2 or more points (compared to previous day)
  • Healthy volunteers:
  • Informed consent

排除标准

  • Common exclusion criteria of all study groups:
  • Inclusion in an interventional study
  • Infectious viral diseases (HBV, HCV, HIV)
  • Iatrogenic immunosuppression
  • Pre-existing autoimmune diseases
  • Treatment with checkpoint inhibitors
  • Specific exclusion criteria of patients with sepsis:
  • Diagnosis sepsis >24 h.
  • Specific exclusion criteria of healthy volunteers:
  • One of the following states during the last 7 days:
  • - Influenza infection or flu
  • - Sports injuries or other trauma
  • - Large-scale dental interventions (e.g., tooth extraction)
  • - Blood or platelet donation.

研究者

发起方
Klinik für Anästhesiologie - Universitätsklinikum Heidelberg

相似试验